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By  appropriate  immunization,  including  infestation  with  the  nematode  Nippo- 
strongylus  brasiliensis to prime T  helper cells that  are specific for this  nematode,  high 
and persistent  IgE antibody has been preferentially obtained in many strains of mice. 
In  the  SJL strain,  however,  the  IgE antibody  response  was  exceptionally  low  and 
transient  when compared to that obtained in other strains  (1, 2). 
Further studies showed that  the transient  IgE antibody response was inherited  as 
a recessive trait and was not linked to the H-2 gene complex, nor to the gene governing 
the inheritance of the Ig-1 allotype (2, 3). High and persistent  IgE antibody responses 
were obtained  in SJL mice when  they were irradiated  after immunization,  and this 
high  and  persistent  IgE  antibody  response  was  selectively  suppressed  by  passive 
transfer of syngeneic normal spleen cells or thymocytes (2, 4). 
It  has  been  shown  in  other  systems  that  T-T-cell  collaboration  is  important  in 
suppression  of antibody  production  (5-11).  Another  immunization  schedule  was, 
therefore, developed to permit  investigation of the mechanism of suppression  of IgE 
antibody  in  SJL  mice.  This  schedule  is  based  on  adoptive  transfer  into  irradiated 
recipients.  IgE antibody-producing B cells are primed with a  haptenic determinant, 
T  helper cells with one carrier,  and other T  cells with the same or a  different carrier. 
The advantages  of this  method of immunization  are  multiple:  the  primed  cells  are 
not irradiated,  the priming of T  cells can be better controlled than  when infestation 
is used, and, finally, experimental  and control mice receive cells from the same pool, 
therefore minimizing individual variations. 
The suppression of antibody production demonstrated in the following experiments 
is different from any other type of suppression  as it is selective for IgE and is brought 
about by two types ofT cell, one of which might have a specificity different from that 
of the helper T  cell. 
Materials  and Methods 
Antigens and Parasite.  Method of culture ofN. brasiliensis (NB) t and preparation of the worm 
antigen (Nb) have been described (1). Proteins and their dinitrophenylated conjugates (DNP- 
proteins) were the same as those previously described (1). 
* Supported by National Institutes of Health grant AI-03075  and National Cancer Institute grant CA- 
16247.  Preliminary  results of interaction  between hyperprimed  and  unprimed  T  cells for  selective 
suppression of IgE anti-DNP production was presented at the CIA meeting in September, 1978 in New 
Orleans. 
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extract of Nippostrongylus brasiliensis worms. 
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Animals.  The  following inbred  mice  were  obtained  from  The Jackson  Laboratory  (Bar 
Harbor,  Maine):  SJL,  ASW,  A/WySn,  C57BL/10,  C3H/He,  and  AKR.  Congenic  inbred 
B10.S  mice  were  a  generous  gift  of Dr.  Phillips-Quagliata  (New  York  University  Medical 
Center, New York).  (SJL  ×  ASW)F1 and  (SJL  ×  B10.S)F1  hybrids were bred  in our animal 
facilities. CFW mice were obtained from Charles River Breeding Laboratories Inc. (Wilmington, 
Mass.).  All mice were female and  8-12 wk old at  the beginning of the experiments.  Sprague 
Dawley male rats, weighing 250-300 g, were obtained from Blue Spruce Farms Inc. (Altamont, 
N. Y.). 
The Adoptive Transfer Method.  Recipient mice were irradiated  1 d  before injection of spleen 
cells from syngeneic donors  with a  dose of 600  rads.  Five recipients were used  per group.  In 
preliminary experiments it was ascertained that no antibody was produced after immunization 
with this sublethal dose of radiation. The radiation was delivered by a Gammator M  apparatus 
(Radiation Machinery Corp. Parsippany,  N. J.) which uses cesium as its source of gamma rays. 
The plastic cage in which the mice were held during radiation could contain five mice. 
The spleen cells of donor mice were gently teased out in sterile Hanks' balanced salt solution 
(HBSS)  (Microbiological Associates, Walkersville,  Md.)  with scissors  and  a  small  forceps on 
melting ice. The cells were filtered through  gauze and  then through  a  small stainless sieve to 
remove tissue debris and clumps, and centrifuged at  170 g for 10 minutes at 4°C. The cells were 
washed three times with cold HBSS and  finally resuspended  in cold HBSS. Cell viability was 
estimated  by  the  trypan  blue  exclusion  test.  Generally  80-92%  of cells  were  viable.  The 
appropriate  number of cells were injected i.v. in 0.2-0.5  ml HBSS and  immediately after the 
animals  were  injected  (challenged)  i.p.  with  the appropriate  antigen  in  0.5  ml sterile saline 
containing  1 or 2 mg AI(OH)3 (See Tables). The animals were bled from the retroorbital sinus 
as described in (2).  Briefly, 0.2 ml blood was mixed with 0.9 ml heparinized saline (10 U/ml), 
centrifuged, and the supernate  was taken  as a  1/10 dilution.  Bleedings from the same groups 
of mice done on the same day were pooled and,  if not  tested  immediately, stored  at  -20°C. 
The  first  bleeding was done  7 d  after challenge and  consecutively every 7 d  for 4  wk.  In the 
Tables, only the second bleeding will be presented, as the titer did not vary much in controls 
after the  2nd  wk and,  in cases when  suppression  occurred,  the titers were the same or even 
lower in the third and fourth bleeding. 
Donor Mice.  One group of donors were healthy uninjected mice; these will be referred to as 
unprimed  mice. The other groups were immunized as listed below. One group of mice (Grl) 
was injected with  1/~g dinitrophenyl-keyhole limpet hemocyanin  (DNP-KLH)  and 3 wk later 
infested with 750 third-stage larvae of NB as described in (1). Spleen cells from these mice were 
harvested 2 wk after infestation. Two groups of mice were injected with  1/tg DNP-KLH. 3 wk 
later, one group  (G 2)  was injected with 0.2 p,g egg albumin  (Ea),  the other group  (G 3) with 
10 #g Ea. The spleen cells from these mice were harvested  7 d  after the injection of Ea. 
One group (G 4) of mice was injected with 0.2 #g DNP-Ea and the spleen cells were harvested 
4  wk later;  a  second  (G 5)  with  1 /zg DNP-KLH and  the spleen cells harvested 4 wk later.  A 
third  group  (G 6)  was injected with  10 ~g Ea twice with a  2-wk interval and  the spleen cells 
harvested  2  wk after  the second  Ea  injection;  a  fourth  with  10 #g  KLH  twice with  a  2-wk 
interval and  the spleen cells harvested  2 wk after the second KLH  injection. The spleen cells 
from  the  last  two  groups  will be  referred  to  as  hyperprimed  cells.  Proteins  and/or  protein- 
hapten conjugates were always injected in donor mice with  1 mg AI(OH)3. 
Antibody Titration.  Anti-DNP antibodies  were titrated  as described  in  (2)  by passive cuta- 
neous  anaphylactic  reactions  (PCA)  in CFW mice for IgGl with a  1.5-h  sensitization  period 
(12)  and rats for IgE (13)  with a  2-h sensitization period (12)  using as challenging antigen 0.5 
mg dinitrophenyl-guinea  pig serum  albumin  for mice and  1 mg dinitrophenyl-bovine serum 
albumin  for  rats.  Doubling  dilutions  were used  and  a  difference less  than  fourfold  was  not 
considered significant. 
Depletion of T Cells  from Spleen Cell Suspension.  Anti-Thy- 1.2 serum was a generous gift of Dr. 
Lloyd Old (Sloan-Kettering Institute for Cancer Research, N. Y.) and rabbit complement  (C) 
was obtained from Accurate Chemical and Scientific Corp.  (Hicksville, N. Y.). This particular 
batch of antiserum was used at a dilution of 1-50 and the rabbit serum as C source at a dilution 
of 1-15. Depletion was done as described in (2). The viability of the spleen cells was tested by 
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Results 
Strain  Difference of Suppression of IgE Antibody  Production by Injection of Unprimed Spleen 
Cells.  Control mice were injected with 3  ×  107 spleen cells which were taken  from 
mice  immunized  with  DNP-KLH,  and  infested  with  NB  as described in  materials 
and  methods  (donor mice G  t). The experimental groups were also injected with  5 
×  107 spleen cells from unprimed donors. Immediately after injection of the cells, the 
animals were challenged with  10/xg of DNP-Nb.  The  antibody titers are shown  in 
Table  I.  Cotransfer  of unprimed  spleen  cells  selectively suppressed  IgE  antibody 
production in SJL, and to a  lesser degree in AKR, but not in other strains of mice. It 
should  be  noted  that  anti-DNP  IgG1  antibody  production  was  not  significantly 
suppressed. 
As the greatest suppression was obtained in the SJL strain of mice, the following 
experiments were performed with this strain. 
Effect of the Dose of Carrier Antigen for Priming on the Suppression of IgE Antibody Production 
by Unprimed Spleen Cells.  To prime for IgE and IgG anti-DNP antibody-producing B 
cells, mice were injected with  1/~g DNP-KLH.  To prime for carrier specific T  cells, 
the mice were supplementarily immunized 3 wk later with 0.2/~g (donor mice G  2) or 
10/tg (donor mice G  3)  Ea. Recipients were injected with 3  X  107 cells of the above 
mentioned donors  (donor mice G  2 or G  3), alone or in addition to the primed cells, 
also with  5  X  10 r  unprimed spleen cells. Challenge was  done with  10 ~g DNP-Ea. 
Results  are  presented  in  Table  II.  The  production  of anti-DNP  IgE  antibody was 
TABLE  I 
Effect of Cotransferred  Syngeneic Unprimed Spleen Cells on Adoptive Secondary 
Response in Various Strains 
Strain§ 
Anti-DNP antibody titers* 
IgE  Ig(3~ 
Transferred  spleen  Transferred  spleen 
cells  cells 
3 X  107  3 X  10  7 
3 ×  107  primed +  3 ×  107  primed + 
primed~:  5 >(  l0 7  primed  5 X  107 
unprimed  unprimed 
SJL  2,560  160  640  320 
ASW  2,560  2,560  160  320 
B 10.S  5,120  2,560  1,280  1,280 
A/WySn  2,560  1,280  320  320 
C57B L/l 0  1,280  640  160  160 
C3H/He  1,280  640  160  160 
AKR  t ,280  320  640  320 
(SJL X ASW)FI  2,560  1,280  320  160 
(SJL ×  BI0.S)FI  5,120  5,120  1,280  640 
*  Anti-DNP antibody was titrated by PCA (see text). Titers taken 2 wk after transfer 
are shown. 
:~ Priming of donors:  1 #g DNP-KLH  +  1 mg AI(OH)3 was injected i.p. 3 wk later, 
the mice were infested with NB. The spleen cells were harvested 2 wk later. 
§ Recipient mice were challenged i.p. immediately after cell transfer with 10 #g DNP- 
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TABLE II 
Effect of the Priming Method on the Suppression Mediated by Unprimed 
Spleen Cells 
Transferred spleen cells  Anti-DNP antibody~: 
3 ×  10  7  5  X  10  7 
primed with*  unprimed  IgE  IgGl 
G 1  DNP-KLH 1 gg 
+  -  1,280  320 
Ea 0.2/tg 
G 2  "  +  1,280  320 
G 3  DNP-KLH l /~g 
+  -  640  320 
Ea l0/tg 
G ~  +  20  160 
* Priming of donors: 1/tg of DNP-KLH +  I mg of AI(OH)a was injected i.p. 
3wklater, 0.2/~gEa  +  1 mgAl(OH)aor 10#gEa  +  1 mgAl(OH)awas 
also injected i.p. Spleen cells were harvested  I wk later. The recipients were 
challenged  immediately after cell transfer  with  10 p.g DNP-Ea  +  1 mg 
AI(OH)a. 
For antibody titration see footnote * of Table I. 
selectively suppressed only in the group of mice which were injected with spleen cells 
from donors primed with the higher amounts of carrier protein (i.e.,  10/tg)  together 
with  unprimed  spleen cells. This  experiment shows  that  the dose of carrier protein 
used for immunization is important to bring about an effective interaction of carrier 
primed T  cells with unprimed spleen cells for selective suppression of anti-DNP IgE 
antibody production. This fact will be commented upon in the Discussion. 
Specificity of the Carrier-primed Suppressor Cells.  In the experiments presented in Table 
II the donor mice were primed first with hapten-carrier conjugate  (DNP-KLH)  then 
with  free heterologous carrier protein  (Ea). To  better demonstrate  the specificity of 
the carrier-primed suppressor cells, separate donors were primed with hapten-carrier 
conjugate (DNP-Ea or DNP-KLH)  and with free carrier proteins (Ea or KLH). Anti- 
DNP antibody titers, 2 wk after challenge in these experiments, are shown  in Table 
III. One-half of the recipients were injected with  1.5  ×  10 7 spleen cells from donors 
primed with 0.2/~g DNP-Ea and divided into six groups (See donor mice, G  4). The 
first  group  to  serve as base-line control was  not  injected with  other cells. All other 
groups were injected in addition with spleen cells taken from different donors as listed 
below: the second group with 5  ×  10 7 spleen cells from unimmunized mice; the third 
with  1  ×  10 7 spleen cells from  donors hyperprimed with Ea  (donor mice, G  6);  the 
fourth with  1  ×  10 7 spleen cells from  donors hyperprimed with  Ea and  in addition 
with  5  ×  10 7 spleen cells from unprimed  donors; the fifth with  1  ×  10 7 spleen cells 
from donors hyperprimed with KLH  (donor mice, G  7);  and the sixth with  1  ×  10 7 
spleen cells from donors hyperprimed with KLH  and in addition with 5  ×  10  7 spleen 
cells from unprimed donors. The challenging antigen was  10 #g DNP-Ea.  The other 
one-half of recipients were used  for a  reverse experiment and were injected with  1.5 
×  10 7 spleen cells from donors primed with  1/~g DNP-KLH  (donor mice G  5). These 
mice were also divided into six groups and were injected exactly like the mice of the 
other one-half of the recipients. However, the challenging antigen in this case was  10 TAKAKI ITAYA  AND ZOLTAN OVARY 
TAaLE  III 
Specificity of Carrier Hyperprimed Cells 
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Transferred spleen cells 
1  X  10 7 
[.5  X  10 7  hyper-  5  X  10 7 
primed with*  primed  unprimed 
with~ 
Antigen challenge§ 
Anti-DNP|I 
IgE  IgGi 
G 1  DNP-Ea  --  -- ]  2,560  320 
G 2  DNP-Ea  --  14- /  2,560  320 
640  160  G 3  DNP-Ea  Ea  DNP-Ea 
G 4  DNP-Ea  Ea  80  320 
G 5  DNP-Ea  KLH  1,280  320 
G 6  DNP-Ea  KLH  1,280  640 
G 7  DNP-KLH  --  -- ]  2,560  320 
G 8  DNP-KLH  --  i+ ]  2,560  640 
G 9  DNP-KLH  KLH  DNP-KLH  640  160 
G 10  DNP-KLH  KLH  20  160 
G 11  DNP-KLH  Ea  1,280  160 
G 12  DNP-KLH  Ea  2,560  320 
* Donor mice were immunized with either 0.2 #g DNP-Ea  +  1 mg AI(OH):~  or with l /Lg DNP-KLH +  I 
mg AI(OH)3 i.p. 4 wk before transfer. 
Donor mice were injected i.p. either with 10 p.g of Ea or with KLH and 1 mg AI(OH)3 two times with 2- 
wk interval. Spleen cells were harvested 2 wk after the second injection. 
§ 10/.tg of DNP-Ea or DNP-KLH and 1 mg AI(OH)a was injected i.p. just after transfer. 
J] Antibody titer was determined 2 wk after transfer. See footnote * of Table ]. 
#g  DNP-KLH.  In  both  cases,  selective suppression  of anti-DNP  IgE  antibody  was 
brought  about  only  when  the  animals  were  injected with  spleen cells  from  carrier 
hyperprimed mice and unprimed mice. Carrier hyperprimed cells alone or unprimed 
cells alone did not  bring about  a  noticeable suppression of anti-DNP  IgE antibody 
production.  It must  be emphasized that  when  unrelated carrier protein was used  to 
hyperprime spleen cells (KLH in the first case:  upper part of Table IiI or Ea:  lower 
part of Table III) no suppression was observed. 
Suppression  of  Anti-Hapten  IgE  Antibody  Production  by  Injection  of  Free  Carrier 
Protein.  Anti-DNP  antibody  titers  2  wk  after  challenge  are  shown  in  Table  IV. 
Recipient mice were divided into two categories. One-haft of them were injected like 
the  group  of mice  shown  in  the  upper  part  of Table  III, omitting  the  two  groups 
injected with spleen cells from mice hyperprimed with the homologous carrier protein 
(i.e., Ea). The mice in these groups were challenged with a  mixture of 10 #g DNP-Ea, 
10 #g KLH, and 2 mg AI(OH).3. The other one-half of the recipients were injected as 
those shown in the lower part of Table III omitting here the two groups injected with 
spleen cells from mice hyperprimed with the homologous carrier protein (i.e., KLH). 
The mice in these groups were challenged with a  mixture of 10 gg of DNP-KLH,  10 
#g  of Ea,  and  2  mg  AI(OH)3.  Anti-DNP  IgE  antibody  production  was  selectively 
suppressed  only  in  those  groups  which  were  injected  with  spleen  cells from  carrier 
hyperprimed  animals  and  unprimed  spleen  cells. It  must  be  noted  that  the carrier 
used  to  hyperprime  donors  was  unrelated  to  the  carrier  conjugated  to  DNP.  The 
important difference between this experiment and the preceding one is that challenge 
was done with two substances: the carrier-hapten conjugate used to prime B cells and 512  MECHANISM  OF  IgE  ANTIBODY  SUPPRESSION 
TABLE  IV 
Suppression of Anti-hapten Antibody Response by Injection of Free Carrier 
Transferred Spleen Cells 
1  X  10  7  Antigen chal- 
1.5  ×  10  7  hyper-  5  X  10  7  lenge§ 
primed with*  primed  unprimed 
with~: 
Anti-DNPII 
IgE  IgG~ 
) 
G  1  DNP-Ea  --  -- ]  DNP-Ea  2,560  160 
G 2  DNP-Ea  --  ~  + ]  2,560  160 
G 3  DNP-Ea  KLH  + 
G 4  DNP-Ea  KLH  KLH  2,560  160  320  80 
G 5  DNP-KLH  --  -- ]  DNP-KLH  2,560  320 
G 6  DNP-KLH  --  ~  /  +  2,560  320 
G  7  DNP-KLH  Ea  Ea  1,280  320 
G 8  DNP-KLH  Ea  320  320 
* Priming with DNP-Ea or DNP-KLH was the same as that described in Table III, foomote  H. 
:~ Hyperpriming was the same as that described in Table III, footnote*. 
§ 10/.tg DNP-Ea, 10/.tg KLH, and 2 mg AI(OH)a were mixed and injected together into mice of G1 to G4 
just after transfer. 10 #g DNP-KLH, 10 gg Ea, and 2 mg AI(OH)a were mixed and injected together i.p. 
into mice of G5 to G8 just after transfer. 
]] Antibody titer was determined 2 wk after transfer. See also footnote* of Table I. 
TABLE  V 
Both Types of Suppressor Cells are Thy-l-Positive Cells 
Transferred spleen cells 
1.5  ×  107  1 X  10  7 hyper-  5  X  10  7  Antigen 
primed with:~  unprimed  challengell 
primed  treated§ or  treated§ or 
with*  untreated  untreated 
Anti-DNP¶ 
lgE  IgG1 
G  1  DNP-KLH  Not injected 
G 2  DNP-KLH  Not injected 
G 3  DNP-KLH  Anti-Thy- 1.2 
and C 
G 4  DNP-KLH  Normal  mouse 
serum and C 
G 5  DNP-KLH  Untreated 
G 6  DNP-KLH  Untreated 
Not injected 
Untreated 
Untreated 
Untreated 
Anti-Thy- 1.2 
and C 
Normal  mouse 
serum and C 
DNP-KLH 
1,280  320 
1,280  320 
640  160 
80  160 
320  160 
80  160 
* Mice were primed with 1 #g DNP-KLH and  1 nag AI(OH)3 i.p. 4 wk before transfer. 
Donors were primed with 10 #g KLH and  1 mg AI(OH)a i.p. two times with 2-wk interval. Spleen cells 
were transferred 2 wk after the second injection. 
§ Anti-Thy-l.2  +  C or normal mouse serum  +  C treatment of transferred cells. 
I[ 10 p.g DNP-KLH and 1 mg AI(OH)a were injected just after transfer. 
¶ Antibody tiler determined 2 wk after transfer. See also footnote* of Table I. 
T  helper  cells and  the  free carrier  used  to  immunize  animals  which  we  term  here  as 
hyperprimed  (also see Discussion). 
Effect  of Anti-Thy and C  Treatment  on  Carrier Hyperprimed and on  Unprimed Cells.  All 
mice  were  injected  with  1.5  ×  107  cells  from  donors  primed  with  DNP-KLH.  All, 
except  group  I,  were  injected  with  5  ×  l07  unprimed  spleen  cells.  In  addition,  four TAKAKI  ITAYA  AND  ZOLTAN  OVARY  513 
groups were also injected with  1  ×  10  7 spleen cells from donors hyperprimed with 
KLH. Both  types of cells,  unprimed  and hyperprimed, were left untreated  or were 
treated with anti-Thy-l.2 and C, as described in Materials and Methods. In controls, 
cells  treated  with  normal  mouse  serum  diluted  1-50  instead  of anti-Thy-l.2  were 
injected.  The results are presented  in Table V. When either of the spleen cells were 
treated  with  anti-Thy-l.2  and  C  there  was  much  less suppression  of IgE antibody 
production  than  when  the same cells were treated  with  normal  mouse serum.  The 
partial  suppression  observed when  the  unprimed  cells  were  treated  with  the  anti- 
serum and the hyperprimed cells were left untreated will be commented upon in the 
Discussion. 
Discussion 
Cotransfer of syngeneic spleen cells  from primed mice and  from unprimed  mice 
into irradiated  mice may bring about a  selective suppression of the hapten-specific 
IgE antibody production in SJL and to a lesser degree in AKR mice (Table I). These 
results confirmed our earlier observations (2, 4, 14). It must be noted that the recipient 
mice, irradiated with 600 rads, which is a sublethal dose of radiation in the SJL strain, 
were unable to produce antibody of any class when they were immunized in the same 
way as those mice which were injected with primed spleen cells, as has been observed 
in preliminary experiments (not shown). 
Using the adoptive transfer method, we confirmed our previous results,  i.e.,  that 
unprimed  T  cells  are  capable  of  selectively  suppressing  IgE  anti-DNP  antibody 
production  (2,  14). One of the advantages of the adoptive transfer method is that all 
mice are  injected  with  primed  and  unprimed  cells  of the  same pools  and  for  this 
reason the control and experimental groups can be compared with greater confidence 
and  precision. The other advantage is that  it  is possible to regulate the number of 
primed cells which cannot be regulated by active immunization. As it is impossible to 
quantitate with precision the antigenic stimulus provoked by infestation with living 
larvae of NB,  we devised a  new schedule  where defined  hapten-protein  conjugates 
were  used  for  immunization.  Using  different  amounts  of  hapten-carrier  protein 
conjugates in several preliminary experiments, it became evident that the population 
of primed cells might contain two types of T  cells:  one which is a T  helper cell; the 
other a T  cell (Table V) which is necessary to bring about anti-DNP IgE suppression, 
and that  the priming of this second type of T  cell  is favored by higher amounts of 
antigen.  The experiments presented in Table II exemplify this point.  In this experi- 
ment,  B  cells  were  primed  with  DNP-KLH,  T  cells  with  Ea.  The  interaction  of 
carrier-primed  (Ea) T  cells and anti-hapten  antibody  (anti-DNP)-producing  B cells 
requires, in most of the cases, that the hapten (DNP) should be coupled to carrier for 
effective challenge.  This  fact was  demonstrated  several years ago when  the  carrier 
effect was first described (15).  Therefore, the challenging antigen was DNP-Ea. Anti- 
DNP IgE antibody was selectively suppressed only in the group which was injected 
concomitantly with spleen cells from donors primed with the higher amount of carrier 
(10 #g) and spleen cells from unprimed donors. 
The  dose  of the  carrier  used  for  priming  therefore  has  a  decisive  influence  in 
selective anti-DNP IgE suppression. 
Okumura  and  Tada  (16)  have  shown  already  that  repeated  injections  of high 
amounts of antigen are very effective to adequately prime suppressor cells. 514  MECHANISM OF IgE ANTIBODY SUPPRESSION 
For this reason, and because of the results of the experiments presented in Table II, 
we hyperprimed donors with higher and repeated injections of a carrier protein and 
used cells from these donors to study the suppression of IgE antibody production by 
cells  from different donors primed  with  low amounts of hapten-carrier conjugates. 
For drastic and selective suppression of IgE antibody production, the simultaneous 
injection of hyperprimed cells and unprimed cells was necessary. Spleen cells, taken 
from donors that were hyperprimed by the same carrier which was used for priming 
the helper T  cells and for challenge, were very effective in the suppression of hapten- 
specific anti-IgE antibody production; spleen cells, from donors hyperprimed by an 
unrelated carrier, however, were without any effect if the free carrier protein was not 
injected with  the challenging antigen  (Table III).  However, when  the  free carrier, 
which was used to hyperprime donors, was mixed with the challenging antigen, very 
effective  and  selective  IgE  suppression  was  obtained  (Table  IV).  Therefore,  the 
priming of T  cells, which plays a crucial role in suppression of selective anti-hapten 
IgE  production,  is  antigen  specific.  However, this  specificity is  not  necessarily the 
same as that of the antigen which primes helper T  cells.  It has been shown with anti- 
Thy-1.2 serum and C that both interacting cells (i.e., the hyperprimed and unprimed) 
are T  cells (Table V). 
It must be emphasized that IgGa anti-DNP antibody was not significantly different 
in control and experimental groups in any of the experiments, therefore, the suppres- 
sion in this system is specific for the production of the IgE class of antibodies. 
The moderate suppression, when only cells from hyperprimed donors were injected 
without  unprimed spleen cells, can be explained by the probable presence of some 
unprimed T  cells in the population of spleen cells from hyperprimed donors (experi- 
ments in Tables II-V). 
Our previous results on IgE suppression were confirmed in other laboratories (17). 
Suppressor cells and suppressor factors for IgE production were also shown by others 
(18-22). However, cellular interactions were not investigated by these authors. 
Tada (5) showed that an Lyt-2,3 suppressor cell produces a suppressor factor which 
then  reacts  with  an  Lyt-l,2,3  cell  which  accepts  this  suppressor  factor  and  an 
amplification loop is interposed before the actual suppressor cells act on the target 
cell.  Eardley et  al.  (7),  Cantor et  al.  (8),  and  McDougal  et  al.  (9),  studying  IgM 
plaque-forming cells in vitro, showed in their system that Lyt- 1 cells may act as helper 
cells for amplifying suppression  and called this  feedback suppression.  However, we 
cannot infer from these in vitro results what could happen  in vivo in regard to IgE 
anti-hapten antibody production. 
It is possible that  the carrier injected into the recipients may induce T  cells from 
the unprimed population for suppressor activity or for amplifying activity. These T 
cells  induced  from the  unprimed  cells could then  interact  with  the carrier specific 
hyperprimed cells.  Another possibility  is  that  the  carrier antigen,  after interacting 
with  the carrier-specific hyperprimed T  cell,  induces suppressor cells  from the  un- 
primed T-cell population in a way similar to that shown by Tada (5)  (see above). 
Still  another  possibility  is  that  the  free  carrier  is  acting  only  on  the  carrier 
hyperprimed cell and  the unprimed T  cell is  in someway necessary to bring about 
suppression. The suppressor cell might act either on the T  helper cell or directly on 
the IgE-producing B cell. A particular aspect of the antibody suppression obtained in 
the  SJL  strain  of mice  is  the  selectivity  for  the  IgE  class  of antibody.  Selective TAKAKI ITAYA AND ZOLTAN OVARY  515 
suppression of IgE class was  also demonstrated by Kishimoto et al.  (19, 20). These 
authors showed that  if before immunization with DNP-ovalbumin mice are preim- 
munized with DNP-coupled mycobacteria, IgE, but not IgG1 anti-DNP and even IgE 
anti-ovalbumin  antibodies,  are  suppressed.  This  suppression  was  caused  by DNP- 
specific suppressor T  cells.  We found in  our experiments that  suppression  of anti- 
hapten IgE antibody production could be induced by carrier-specific T  cells, but only 
when the challenging antigen contained the same carrier, albeit unconjugated to the 
challenging  hapten-carrier  conjugate.  In  addition,  an  interaction  between  these 
hyperprimed T  cells and unprimed T  cells was necessary. 
The  type  of suppression  described  in  this  work  is  quite  different  from  types 
previously described for the following reasons:  it is class specific (only IgE antibody 
is suppressed);  it results from the interaction of two sets of T  cells, one hyperprimed 
and the other unprimed; and finally, the specificity of the hyperprimed T  cells can be 
unrelated to the specificity of the helper T  cells. 
Summary 
The mechanism of selective anti-hapten  IgE antibody production was studied  in 
SJL mice. Using an adoptive transfer method of spleen cells into syngeneic recipients 
irradiated  with  a  sublethal  dose  of 600  rads,  it  was  demonstrated  that  for  the 
suppression of anti-dinitrophenyl (DNP) IgE antibody production the interaction of 
two subsets of T  cells is necessary. DNP-primed B cells and carrier-primed T  helper 
cells are taken from donors primed with small amounts of DNP-carrier conjugates. 
Without  injection of other cells, high  titer and  persistent  anti-DNP  antibodies  are 
produced in the recipients. The two subsets of T  cells that are active in suppression of 
IgE are taken from two types of donors: one donor is immunized (hyperprimed) with 
larger amounts of carrier protein twice, the other is an unprimed donor. The carrier 
for hyperpriming the  first  type of donor may be unrelated  to the carrier used  for 
priming the helper T  cells.  To bring about anti-DNP IgE suppression it is necessary 
that the animals should be challenged with the same DNP-carrier conjugate used for 
priming the B and T  helper cells. If the hyperprimed donors were immunized with a 
heterologous, unrelated carrier, then this heterologous unconjugated carrier must also 
be injected together with the homologous DNP-carrier conjugate. In these conditions, 
anti-DNP  IgE antibody production is suppressed, but  the production of anti-DNP 
IgG1 antibody is not diminished. 
Received  for publication 17 April 1979. 
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